Journament

Keyword Connections - myelodysplastic syndrome Keywords

Connection Type	Connection
Journals	clinical epigenetics clinical lymphoma, myeloma & leukemia Leukemia & lymphoma Anales del sistema sanitario de Navarra
Research Groups	No Research Group Connected
Bibliographies	[1] Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System. [2] modeling myeloid malignancies using zebrafish [3] diagnostic utility of flow cytometry in myelodysplastic syndromes. [4] Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice. [5] [Solitary dorsal paravertebral tumor: radiological and histopathological characterization of a pediatric case of nodular fasciitis]. [6] Impact of red blood cell transfusion dose density on progression-free survival in lower-risk myelodysplastic syndromes patients. [7] Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome. [8] Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System. [9] Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia [10] Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence. [11] Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature. [12] Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial. [13] Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes — first experience with their reversal [14] Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias [15] FAB classification of myelodysplastic syndromes: merits and controversies [16] Is splenectomy a contraindication for patients with myelodysplastic syndromes complicated by splenomegaly? [17] Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems [18] Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study [19] importance of classical morphology in the diagnosis of myelodysplastic syndrome [20] decitabine-induced changes in human myelodysplastic syndrome cell line skm-1 are mediated by foxo3a activation [21] scientific comment on tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome [22] a paraneoplastic syndrome characterized by extremity swelling with associated inflammatory infiltrate heralds aggressive transformation of myelodysplastic syndromes/myeloproliferative neoplasms to acute myeloid leukemia: a case series [23] síndrome mielodisplásica na infância myelodysplastic syndromes in childhood [24] diagnostic utility of flow cytometry in myelodysplastic syndromes. [25] plasma protein biomarker candidates for myelodysplastic syndrome subgroups [26] cytogenetic as an important tool for diagnosis and prognosis for patients with hypocellular primary myelodysplastic syndrome [27] our treatment experience with azacytidine in patients with acute myeloid leukaemia, chronic myelomonocytic leukaemia and myelodysplastic syndrome [28] npm1 gene mutations in children with myelodysplastic syndromes [29] high incidence of gastrointestinal ulceration and cytogenetic aberration of trisomy 8 as typical features of behçet’s disease associated with myelodysplastic syndrome: a series of 16 consecutive chinese patients from the shanghai behçet’s disease database and comparison with the literature [30] acquired elliptocytosis as a manifestation of myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia [31] Saccharomyces cerevisiae septicemia in a patient with myelodysplastic syndrome [32] Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice.